Lazard Capital Markets downgrades Human Genome Sciences (Nasdaq: HGSI) from Hold to Sell.
This article: 63 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE